Page last updated: 2024-11-05

ethidium bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Ethidium bromide is a fluorescent dye that binds to DNA. It is commonly used in molecular biology laboratories to visualize DNA in electrophoresis gels. Ethidium bromide is a planar molecule that intercalates between the base pairs of DNA. When exposed to UV light, ethidium bromide fluoresces, making the DNA bands visible. The synthesis of ethidium bromide involves a multi-step process that starts with the reaction of 2-amino-5-nitrophenol with 1,3-dichloro-2-propanol to form 2-amino-5-nitro-1,3-dihydroxypropane. This compound is then reacted with 1,3-diphenyl-2-propanone to form the ethidium bromide molecule. Ethidium bromide has been shown to be a potent mutagen and carcinogen. It is believed to cause mutations by intercalating into DNA and disrupting its replication. Due to its potential hazards, the use of ethidium bromide is being replaced by safer alternatives, such as SYBR Green. Ethidium bromide is studied because of its ability to bind to DNA and its potential applications in molecular biology research. The use of ethidium bromide is still relevant for some applications, such as visualizing DNA in agarose gels, but its use should be carefully considered and replaced with safer alternatives whenever possible. '

Cross-References

ID SourceID
PubMed CID14710
CHEMBL ID284328
CHEBI ID4883
SCHEMBL ID20520
SCHEMBL ID1505620
MeSH IDM0007861

Synonyms (95)

Synonym
smr001566146
j mol biol 13: 269 (1965); 27: 87 (1967)
dromilac
2,7-diamino-9-phenyl-10-ethylphenanthridinium bromide
wln: t b666 hkj ej h2 ir& lz &e &9/26
phenanthridinium,8-diamino-5-ethyl-6-phenyl-, bromide
ethydium bromide
nsc268986 ,
3,8-diamino-5-ethyl-6-phenylphenanthridinium bromide
nsc-268986
mls002702536 ,
2,7-diamino-9-phenylphenanthridine ethobromide
2,7-diamino-10-ethyl-9-phenylphenanthridinium bromide
NCGC00091387-01
phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, bromide
ccris 1017
rd 1572
bromure d'homidium [inn-french]
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
homidium bromide [inn:ban]
einecs 214-984-6
bromuro de homidio [inn-spanish]
homidii bromidum [inn-latin]
hsdb 7297
ai3-62997
nsc 268986
1239-45-8
homidium bromide
ethidium bromide ,
ethidium bromide, bioreagent, for molecular biology, powder
ethidium bromide, ~95% (hplc)
NCGC00095070-02
NCGC00095070-01
CHEBI:4883 ,
etbr
SPECTRUM1503806
E-4000
ethidium bromide, for fluorescence, >=95.0% (hplc)
CHEMBL284328 ,
HMS502O22
E0370
HMS1922I08
bromuro de homidio
bromure d'homidium
unii-059nuo2z1l
homidii bromidum
059nuo2z1l ,
NCGC00260060-01
tox21_202511
nsc758630
pharmakon1600-01503806
nsc-758630
tox21_111123
cas-1239-45-8
dtxsid8025258 ,
dtxcid605258
tox21_111410
CCG-39365
FT-0614786
AM84361
AKOS015904050
homidium bromide [hsdb]
homidium bromide [mi]
homidium bromide [mart.]
homidium bromide [inn]
SCHEMBL20520
tox21_111410_1
NCGC00091387-08
ZMMJGEGLRURXTF-UHFFFAOYSA-N
3,8-diamino-5-ethyl-6-phenylphenanthridin-5-ium bromide
SCHEMBL1505620
mfcd00011724
c21h20brn3
sr-01000872761
SR-01000872761-1
ethidium bromide, >=95.0%
ethidium bromide, ~10 mg/tablet ethidium bromide, tablet
ethidium bromide, electrophoresis grade
ethidium bromide, vetec(tm) reagent grade, 95%
ethidium bromide, 98%
ethidium bromide, for biochemistry, 98%
phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, bromide (1:1)
F16485
5-ethyl-6-phenylphenanthridin-5-ium-3,8-diamine;bromide
HMS3868D03
AS-79030
ethidium bromide solution, 10mg/ml in h2o
HB9326
3,8-diamino-5-ethyl-6-phenylphenanthridium bromide
CS-0009917
HY-D0021
ethidium (bromide)
ethidiumbromide
E1363
ethidium bromide (0.5mg/ml in water) (in dropper bottle) [for electrophoresis]

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
trypanocidal drugA drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
intercalatorA role played by a chemical agent which exhibits the capability of occupying space between DNA base pairs due to particular properties in size, shape and charge. Intercalation of chemical compounds in DNA helix can result in replication errors (shift, mutation) or DNA damages.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic bromide salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Mitochondrial unfolded-protein response02

Protein Targets (127)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency31.62280.003245.467312,589.2998AID2517
Chain A, Breast cancer type 1 susceptibility proteinHomo sapiens (human)Potency24.11751.258920.440939.8107AID875; AID892
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency1.25890.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency50.11870.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency1.00000.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency35.48130.125919.1169125.8920AID2549
acetylcholinesteraseHomo sapiens (human)Potency34.19470.002541.796015,848.9004AID1347395; AID1347397; AID1347398
glp-1 receptor, partialHomo sapiens (human)Potency5.62340.01846.806014.1254AID624417
15-lipoxygenase, partialHomo sapiens (human)Potency10.00000.012610.691788.5700AID887
WRNHomo sapiens (human)Potency2.99350.168331.2583100.0000AID651768
phosphopantetheinyl transferaseBacillus subtilisPotency44.66840.141337.9142100.0000AID1490
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency26.02973.189029.884159.4836AID1224846; AID1224894
Fumarate hydrataseHomo sapiens (human)Potency4.46680.00308.794948.0869AID1347053
USP1 protein, partialHomo sapiens (human)Potency26.35170.031637.5844354.8130AID504865; AID743255
TDP1 proteinHomo sapiens (human)Potency0.27610.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency22.67150.000714.592883.7951AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency6.68970.180013.557439.8107AID1460; AID1468
AR proteinHomo sapiens (human)Potency14.11700.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID588516; AID743035; AID743036; AID743042; AID743053; AID743054; AID743063
Smad3Homo sapiens (human)Potency7.07950.00527.809829.0929AID588855
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency19.93520.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency39.81070.00137.762544.6684AID2120
thyroid stimulating hormone receptorHomo sapiens (human)Potency31.62280.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency9.90080.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency17.95840.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency25.85390.000417.946075.1148AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency1.54870.01237.983543.2770AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency5.50350.000214.376460.0339AID588532; AID588533; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency23.30100.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency4.51860.000817.505159.3239AID1159527; AID588544; AID588546
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.38240.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency8.93170.375827.485161.6524AID588526; AID743217; AID743220
estrogen nuclear receptor alphaHomo sapiens (human)Potency28.18310.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID588513; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
GVesicular stomatitis virusPotency27.54040.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency3.46710.00108.379861.1304AID1645840
polyproteinZika virusPotency4.46680.00308.794948.0869AID1347053
67.9K proteinVaccinia virusPotency11.03130.00018.4406100.0000AID720579; AID720580
luciferasePhoturis pensylvanica (Pennsylania firefly)Potency15.84890.891310.432820.5750AID1379
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency26.58810.001024.504861.6448AID588535; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency40.06480.001019.414170.9645AID588537; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency15.69680.023723.228263.5986AID743223
alpha-galactosidaseHomo sapiens (human)Potency35.48134.466818.391635.4813AID2107
IDH1Homo sapiens (human)Potency14.58100.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency2.81840.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency22.42400.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency19.19070.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency31.01960.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259395
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency18.467519.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency21.77610.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency80.01120.039147.5451146.8240AID1224845; AID1224896
Bloom syndrome protein isoform 1Homo sapiens (human)Potency39.81070.540617.639296.1227AID2528
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency3.00160.316212.443531.6228AID902; AID924
tumor necrosis factorHomo sapiens (human)Potency37.57800.375823.492842.1632AID651757
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency35.48130.001815.663839.8107AID894
runt-related transcription factor 1 isoform AML1bHomo sapiens (human)Potency10.93210.02007.985839.8107AID504370; AID504374; AID504375
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency43.31750.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency70.79460.006026.168889.1251AID540317
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency28.66080.010039.53711,122.0200AID1469; AID1479; AID588545; AID588547
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency14.58100.00419.984825.9290AID504444
transcriptional regulator ERG isoform 3Homo sapiens (human)Potency15.84890.794321.275750.1187AID624246
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency25.70840.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency25.06550.042027.378961.6448AID743210
core-binding factor subunit beta isoform 2Homo sapiens (human)Potency10.93210.02007.985839.8107AID504370; AID504374; AID504375
huntingtin isoform 2Homo sapiens (human)Potency18.25630.000618.41981,122.0200AID1688
mitogen-activated protein kinase 1Homo sapiens (human)Potency25.11890.039816.784239.8107AID995
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency22.38724.466824.832944.6684AID651749
flap endonuclease 1Homo sapiens (human)Potency14.76670.133725.412989.1251AID588795; AID720498
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency40.07490.010323.856763.0957AID2662
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency9.53250.000627.21521,122.0200AID651741; AID743202; AID743219
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency75.68630.425612.059128.1838AID504891
DNA polymerase eta isoform 1Homo sapiens (human)Potency32.29330.100028.9256213.3130AID588591; AID720502
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency27.40680.050127.073689.1251AID588590; AID720496
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency19.30720.00798.23321,122.0200AID2546; AID2551
DNA polymerase kappa isoform 1Homo sapiens (human)Potency11.81100.031622.3146100.0000AID588579; AID720501
VprHuman immunodeficiency virus 1Potency3.98111.584919.626463.0957AID651644
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency7.75150.005612.367736.1254AID624032; AID624044
survival motor neuron protein isoform dHomo sapiens (human)Potency10.00000.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency8.15480.031610.279239.8107AID884; AID885
caspase-1 isoform alpha precursorHomo sapiens (human)Potency6.47760.000311.448431.6228AID900
lethal factor (plasmid)Bacillus anthracis str. A2012Potency2.51190.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency22.38720.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency24.14950.001557.789015,848.9004AID1259244
Interferon betaHomo sapiens (human)Potency27.54040.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency27.54040.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency6.10710.002319.595674.0614AID651631; AID651743; AID720552
Integrin beta-3Homo sapiens (human)Potency3.98110.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency3.98110.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency24.14950.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Platelet-activating factor receptorHomo sapiens (human)Potency29.881610.000025.781039.8107AID892
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Caspase-7Homo sapiens (human)Potency6.30963.981118.585631.6228AID889
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Guanine nucleotide-binding protein GHomo sapiens (human)Potency35.48131.995325.532750.1187AID624288
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency27.54040.01238.964839.8107AID1645842
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency18.70940.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency20.14690.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency8.15481.000012.224831.6228AID885
cytochrome P450 2C9, partialHomo sapiens (human)Potency27.54040.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
polyadenylate-binding protein 1Homo sapiens (human)IC50 (µMol)53.19004.910023.702976.1900AID602259; AID602260
Telomerase reverse transcriptaseHomo sapiens (human)IC50 (µMol)2.59000.00062.69489.4000AID1067699; AID1191411; AID1204358; AID1287127; AID212907; AID212908; AID212909; AID516696; AID537601; AID594636; AID653484; AID725721; AID735444
60 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)100.00000.17004.559010.0000AID1594139
10 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)100.00000.17004.559010.0000AID1594139
Thiosulfate sulfurtransferaseHomo sapiens (human)IC50 (µMol)0.83000.06003.96319.7000AID1594135
60 kDa chaperonin Escherichia coliIC50 (µMol)51.20000.03903.55529.8000AID1594140; AID1594141
Reverse transcriptase/RNaseH Human immunodeficiency virus 1IC50 (µMol)2.00000.00011.076810.0000AID695925
10 kDa chaperonin Escherichia coliIC50 (µMol)51.20000.03903.55529.8000AID1594140; AID1594141
putative polyproteinIC50 (µMol)2.43950.25083.82838.4620AID720577; AID720578
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Multidrug resistance protein MdtKEscherichia coli K-12Kd9.80009.80009.80009.8000AID572158
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Microphthalmia-associated transcription factorHomo sapiens (human)AC509.11600.015010.904946.0480AID493073; AID493102; AID493177; AID493191; AID493240
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7Homo sapiens (human)AC507.74000.039815.002550.0000AID743267
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)Mycobacterium tuberculosis H37RvAC5027.44002.730045.826498.7200AID624273
histone-lysine N-methyltransferase NSD2 isoform 1Homo sapiens (human)AC500.29300.29307.307019.4400AID1053173
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (366)

Processvia Protein(s)Taxonomy
telomere maintenanceTelomerase reverse transcriptaseHomo sapiens (human)
RNA-templated transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
RNA-templated DNA biosynthetic processTelomerase reverse transcriptaseHomo sapiens (human)
telomere maintenance via telomeraseTelomerase reverse transcriptaseHomo sapiens (human)
mitochondrion organizationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of gene expressionTelomerase reverse transcriptaseHomo sapiens (human)
DNA strand elongationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of Wnt signaling pathwayTelomerase reverse transcriptaseHomo sapiens (human)
siRNA processingTelomerase reverse transcriptaseHomo sapiens (human)
regulation of protein stabilityTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of hair cycleTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of neuron apoptotic processTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of angiogenesisTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of glucose importTelomerase reverse transcriptaseHomo sapiens (human)
response to cadmium ionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityTelomerase reverse transcriptaseHomo sapiens (human)
establishment of protein localization to telomereTelomerase reverse transcriptaseHomo sapiens (human)
cellular response to hypoxiaTelomerase reverse transcriptaseHomo sapiens (human)
DNA biosynthetic processTelomerase reverse transcriptaseHomo sapiens (human)
replicative senescenceTelomerase reverse transcriptaseHomo sapiens (human)
siRNA transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of miRNA transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of transdifferentiationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of protein localization to nucleolusTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell migrationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of endothelial cell apoptotic processTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of stem cell proliferationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of cellular senescenceTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandTelomerase reverse transcriptaseHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
protein folding60 kDa chaperoninEscherichia coli K-12
response to radiation60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
virion assembly60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
protein refolding60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
adhesion of symbiont to host60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell mediated immune response to tumor cell60 kDa heat shock protein, mitochondrialHomo sapiens (human)
'de novo' protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to cold60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interferon-alpha production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-10 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-12 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-6 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein refolding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell proliferation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of macrophage activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isotype switching to IgG isotypes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein stabilization60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone-mediated protein complex assembly60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein maturation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
biological process involved in interaction with symbiont60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cellular response to interleukin-760 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein import into mitochondrial intermembrane space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial unfolded protein response60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apoptotic mitochondrial changes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of cellular extravasationPlatelet-activating factor receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIPlatelet-activating factor receptorHomo sapiens (human)
chemotaxisPlatelet-activating factor receptorHomo sapiens (human)
inflammatory responsePlatelet-activating factor receptorHomo sapiens (human)
immune responsePlatelet-activating factor receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
parturitionPlatelet-activating factor receptorHomo sapiens (human)
response to symbiotic bacteriumPlatelet-activating factor receptorHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of interleukin-6 productionPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of tumor necrosis factor productionPlatelet-activating factor receptorHomo sapiens (human)
inositol trisphosphate biosynthetic processPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of neutrophil degranulationPlatelet-activating factor receptorHomo sapiens (human)
transcytosisPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of translationPlatelet-activating factor receptorHomo sapiens (human)
negative regulation of blood pressurePlatelet-activating factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processPlatelet-activating factor receptorHomo sapiens (human)
cellular response to gravityPlatelet-activating factor receptorHomo sapiens (human)
cellular response to cAMPPlatelet-activating factor receptorHomo sapiens (human)
cellular response to fatty acidPlatelet-activating factor receptorHomo sapiens (human)
response to dexamethasonePlatelet-activating factor receptorHomo sapiens (human)
positive regulation of leukocyte tethering or rollingPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of transcytosisPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of maternal process involved in parturitionPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of gastro-intestinal system smooth muscle contractionPlatelet-activating factor receptorHomo sapiens (human)
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholinePlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
sodium ion transportMultidrug resistance protein MdtKEscherichia coli K-12
xenobiotic transmembrane transportMultidrug resistance protein MdtKEscherichia coli K-12
protein transportMultidrug resistance protein MdtKEscherichia coli K-12
peptide transportMultidrug resistance protein MdtKEscherichia coli K-12
cellular response to reactive oxygen speciesMultidrug resistance protein MdtKEscherichia coli K-12
dipeptide transmembrane transportMultidrug resistance protein MdtKEscherichia coli K-12
response to antibioticMultidrug resistance protein MdtKEscherichia coli K-12
transmembrane transportMultidrug resistance protein MdtKEscherichia coli K-12
xenobiotic detoxification by transmembrane export across the plasma membraneMultidrug resistance protein MdtKEscherichia coli K-12
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
osteoblast differentiation10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process10 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein10 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone cofactor-dependent protein refolding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
sulfur amino acid catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
cyanate catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
epithelial cell differentiationThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA import into mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA transportThiosulfate sulfurtransferaseHomo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (114)

Processvia Protein(s)Taxonomy
tRNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
transcription coactivator bindingTelomerase reverse transcriptaseHomo sapiens (human)
DNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
telomerase activityTelomerase reverse transcriptaseHomo sapiens (human)
telomerase RNA reverse transcriptase activityTelomerase reverse transcriptaseHomo sapiens (human)
RNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
RNA-directed DNA polymerase activityTelomerase reverse transcriptaseHomo sapiens (human)
RNA-dependent RNA polymerase activityTelomerase reverse transcriptaseHomo sapiens (human)
protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
identical protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
protein homodimerization activityTelomerase reverse transcriptaseHomo sapiens (human)
metal ion bindingTelomerase reverse transcriptaseHomo sapiens (human)
protein-folding chaperone bindingTelomerase reverse transcriptaseHomo sapiens (human)
telomerase RNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
template-free RNA nucleotidyltransferaseTelomerase reverse transcriptaseHomo sapiens (human)
telomeric DNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
magnesium ion binding60 kDa chaperoninEscherichia coli K-12
protein binding60 kDa chaperoninEscherichia coli K-12
ATP binding60 kDa chaperoninEscherichia coli K-12
isomerase activity60 kDa chaperoninEscherichia coli K-12
ATP hydrolysis activity60 kDa chaperoninEscherichia coli K-12
identical protein binding60 kDa chaperoninEscherichia coli K-12
unfolded protein binding60 kDa chaperoninEscherichia coli K-12
ATP-dependent protein folding chaperone60 kDa chaperoninEscherichia coli K-12
lipopolysaccharide binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
p53 binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
DNA replication origin binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
single-stranded DNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
double-stranded RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
high-density lipoprotein particle binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isomerase activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP hydrolysis activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
enzyme binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ubiquitin protein ligase binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein A-I binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP-dependent protein folding chaperone60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lipopolysaccharide bindingPlatelet-activating factor receptorHomo sapiens (human)
lipopolysaccharide immune receptor activityPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled receptor activityPlatelet-activating factor receptorHomo sapiens (human)
platelet activating factor receptor activityPlatelet-activating factor receptorHomo sapiens (human)
protein bindingPlatelet-activating factor receptorHomo sapiens (human)
phospholipid bindingPlatelet-activating factor receptorHomo sapiens (human)
mitogen-activated protein kinase bindingPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityPlatelet-activating factor receptorHomo sapiens (human)
antiporter activityMultidrug resistance protein MdtKEscherichia coli K-12
xenobiotic transmembrane transporter activityMultidrug resistance protein MdtKEscherichia coli K-12
dipeptide transmembrane transporter activityMultidrug resistance protein MdtKEscherichia coli K-12
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
RNA binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding chaperone10 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
metal ion binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
thiosulfate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
5S rRNA bindingThiosulfate sulfurtransferaseHomo sapiens (human)
3-mercaptopyruvate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (83)

Processvia Protein(s)Taxonomy
PML bodyTelomerase reverse transcriptaseHomo sapiens (human)
chromosome, telomeric regionTelomerase reverse transcriptaseHomo sapiens (human)
nucleusTelomerase reverse transcriptaseHomo sapiens (human)
nucleoplasmTelomerase reverse transcriptaseHomo sapiens (human)
telomerase holoenzyme complexTelomerase reverse transcriptaseHomo sapiens (human)
nucleolusTelomerase reverse transcriptaseHomo sapiens (human)
cytosolTelomerase reverse transcriptaseHomo sapiens (human)
plasma membraneTelomerase reverse transcriptaseHomo sapiens (human)
nuclear speckTelomerase reverse transcriptaseHomo sapiens (human)
mitochondrial nucleoidTelomerase reverse transcriptaseHomo sapiens (human)
TERT-RMRP complexTelomerase reverse transcriptaseHomo sapiens (human)
telomerase catalytic core complexTelomerase reverse transcriptaseHomo sapiens (human)
nuclear telomere cap complexTelomerase reverse transcriptaseHomo sapiens (human)
RNA-directed RNA polymerase complexTelomerase reverse transcriptaseHomo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
cytoplasm60 kDa chaperoninEscherichia coli K-12
cytosol60 kDa chaperoninEscherichia coli K-12
membrane60 kDa chaperoninEscherichia coli K-12
GroEL-GroES complex60 kDa chaperoninEscherichia coli K-12
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytoplasm60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrion60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
early endosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytosol60 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
clathrin-coated pit60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cell surface60 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
coated vesicle60 kDa heat shock protein, mitochondrialHomo sapiens (human)
secretory granule60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm midpiece60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
migrasome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-containing complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lipopolysaccharide receptor complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
plasma membranePlatelet-activating factor receptorHomo sapiens (human)
membranePlatelet-activating factor receptorHomo sapiens (human)
secretory granule membranePlatelet-activating factor receptorHomo sapiens (human)
tertiary granule membranePlatelet-activating factor receptorHomo sapiens (human)
plasma membraneMultidrug resistance protein MdtKEscherichia coli K-12
membraneMultidrug resistance protein MdtKEscherichia coli K-12
membraneMultidrug resistance protein MdtKEscherichia coli K-12
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
mitochondrion10 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane10 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome10 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix10 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
extracellular spaceThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrial matrixThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (537)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347114qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347109qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347116qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347118qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347126qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347125qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347129qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347115qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347121qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347119qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347113qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347112qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347122qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347127qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347124qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347128qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347110qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells)2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347117qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347111qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347123qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID585913Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID405379Toxicity against human HepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 10 days relative to control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID406648Antibacterial activity against Staphylococcus aureus ACH-0206 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID72882Thermal denaturation in alternating poly(dG-dC)-poly(dG-dC) homopolymer (GC)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID585492Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1502708Antimycobacterial activity against Mycobacterium avium 104 mc'2 4 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1743674Antimycobacterial activity against Mycobacterium smegmatis mc2 155 ATCC 700084 assessed as inhibition of visible growth of bacteria by MTT assay2020European journal of medicinal chemistry, Dec-01, Volume: 207Palladium-catalysed synthesis of arylnaphthoquinones as antiprotozoal and antimycobacterial agents.
AID576020Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID586118Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585907Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID339766Binding affinity to synthetic poly(dA-dT):poly(dA-dT) DNA:DNA duplex assessed as association constant at 20 degC2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Molecular recognition of a DNA:RNA hybrid: sub-nanomolar binding by a neomycin-methidium conjugate.
AID1447307Inhibition of DNA topoisomerase-1 (unknown origin) mediated DNA relaxation assessed as DNA intercalation at 1 ug/ml using supercoiled pBR322 plasmid DNA as substrate after 60 mins by ethidium bromide staining based agarose gel electrophoresis2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
AID1339148Binding affinity to synthetic biotin-labeled 30-mer AT-rich duplex DNA in pH 7.8 Tris-Hcl buffer solution assessed as ratio of association rate constant to dissociation rate constant in presence of 0.1 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID576015Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID736816Induction of DNA intercalation in negatively Escherichia coli super coiled small circular plasmid DNA assessed as retradation of DNA migration at 100 uM incubated for 20 mins at 37 degC by agarose-gel electrophoresis2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.
AID1197382Binding affinity to Escherichia coli pBR322 DNA assessed as DNA intercalation activity compound preincubated for 10 mins before enzyme addition by DNA unwinding assay in presence of topoisomerase 12015European journal of medicinal chemistry, Mar-06, Volume: 92Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
AID1413834Induction of Escherichia coli pBR322 DNA intercalation assessed as transformation of topoisomerase1-relaxed pBR322 DNA in to supercoiled DNA at 5 uM preincubated for 10 mins followed by topoisomerase-1 addition and measured after 30 mins by agarose gel el2018MedChemComm, Jul-01, Volume: 9, Issue:7
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.
AID586113Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1339145Binding affinity to synthetic biotin-labeled 30-mer AT-rich duplex DNA in pH 7.8 Tris-Hcl buffer solution assessed as association rate constant in presence of 0.1 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID532761Antimicrobial activity against Salmonella serovar Virchow 5742 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID520086Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring AcrAB efflux pump by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID585731Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586129Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585911Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID532573Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID510748Antibacterial activity against Escherichia coli AG102MB harboring naive acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID585901Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586102Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1651227Binding affinity to supercoiled DNA (unknown origin) by SPR assay2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.
AID1502713Antimycobacterial activity against Mycobacterium avium isolate MAV4 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID585912Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585697Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1888866Bactericidal activity against Staphylococcus aureus 1199B assessed as log reduction in bacterial count at 50 ug/mL measured after 8 hrs by time-kill kinetics assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID532763Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1359222Induction of unwinding effect of Escherichia coli supercoiled pBR322 DNA at 0.3 to 1.2 mg/L preincubated with DNA for 10 mins followed by excess calf thymus TOP1 addition and measured after 30 mins by agarose gel electrophoresis2018European journal of medicinal chemistry, May-25, Volume: 152Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors.
AID510559Antibacterial activity against Escherichia coli AG102MB2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID586099Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586096Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID472809Inhibition of HCV genotype 1b NS5B polymerase deltaC21 mutant2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
AID644952Binding affinity to human pre-hsa-mir-155 miRNA assessed as increase in fluorescence after 30 mins by fluorimetry2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
AID1356628Antimicrobial activity against Staphylococcus aureus ATCC 25923 by microdilution method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID520082Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring AheABC efflux pump by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID584116Ratio of MIC for Escherichia coli KAM32 harboring cloned pSP72 lmrS to MIC for Escherichia coli KAM32 harboring pSP722010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID510749Antibacterial activity against Escherichia coli AG102MB harboring pP10-based acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID586088Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585728Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1594135Inhibition of native rhodanese (unknown origin) assessed as reduction in rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID406655Antibacterial activity against Staphylococcus aureus ACH-0192 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID283560Antibacterial activity against Escherichia coli HNCE4 after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID585711Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585899Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585888Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586097Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID532762Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID585708Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586106Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585902Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585919Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID388885DNA intercalative activity assessed retardation in migration of negatively supercoiled small circular Escherichia coli pBSKS in agarose gel electrophoresis at 100 uM2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors.
AID472816Inhibition of HCV genotype 1b NS5B polymerase deltaC21 M423K mutant2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
AID1419492Binding affinity to calf thymus DNA by TLC plate based assay2017European journal of medicinal chemistry, May-05, Volume: 131Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
AID660265Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump2012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID582815Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406646Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID1362612Binding affinity to calf thymus DNA assessed as increase in viscosity at 15 uM by viscometric method2018Bioorganic & medicinal chemistry, 09-15, Volume: 26, Issue:17
Synthesis of DNA interactive C3-trans-cinnamide linked β-carboline conjugates as potential cytotoxic and DNA topoisomerase I inhibitors.
AID532755Antimicrobial activity against Salmonella serovar Heidelberg 5171 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID405373Toxicity against human H9c2 cells assessed as inhibition of cell proliferation at 0.5 ug/ml after 6 days by SRB assay2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID1586738Inhibition of calf thymus topoisomerase-1-mediated relaxed pBR322 DNA unwinding at 25 uM preincubated with DNA for 10 mins followed by enzyme addition and measured after 30 mins by agarose gel electrophoresis assay2018Journal of natural products, 12-28, Volume: 81, Issue:12
Eucalypglobulusals A-J, Formyl-Phloroglucinol-Terpene Meroterpenoids from Eucalyptus globulus Fruits.
AID585729Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586104Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585706Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1888846Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID678964TP_TRANSPORTER: uptake in BCRP-expressing Lactococcus lactis cells2003The Journal of biological chemistry, Jun-06, Volume: 278, Issue:23
Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis.
AID585689Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1356634Antimicrobial activity against mepA deficient Staphylococcus aureus SA-K2885 by microdilution method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID585892Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID26756DNA binding dissociation constant as KD1984Journal of medicinal chemistry, Apr, Volume: 27, Issue:4
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
AID582818Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID520087Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring AheABC efflux pump by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID1356632Antimicrobial activity against NorA deficient Staphylococcus aureus SA-K1902 by microdilution method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID585710Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406658Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID1594140Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID405375Toxicity against human H9c2 cells assessed as elevation of lactate levels at 0.5 ug/ml after 6 days by NAD+ reduction assay2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID585707Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585482Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID396282Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID405467Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID585683Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1502707Antimycobacterial activity against Mycobacterium avium 104 mc'2 3 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1067699Inhibition of telomerase in human MGC803 cell extracts after 24 hrs by TRAP-PCR-ELISA2014European journal of medicinal chemistry, Mar-03, Volume: 74Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
AID586103Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585681Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585698Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585908Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID374689Antimicrobial activity against totarol-resistant Staphylococcus aureus K30902007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID406649Antibacterial activity against Staphylococcus aureus ACH-0221 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID1428614Inhibition of recombinant human topoisomerase-1 assessed as DNA insertion by measuring drug-DNA-enzyme ternary complex formation up to 25 uM using supercoiled pBR322 DNA substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresi2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.
AID532584Antimicrobial activity against Salmonella serovar Enteritidis 5188 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID586114Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585691Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1339146Binding affinity to synthetic biotin-labeled 30-mer AT-rich duplex DNA in pH 7.8 Tris-Hcl buffer solution assessed as dissociation rate constant in presence of 0.1 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID1594139Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID406812Antibacterial activity against Staphylococcus aureus BSA678 isolate with gyrA Ser84Leu, Ser85Pro and grlA Ser80Phe, Glu84Gly mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID585712Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID472813Antiviral activity against Hepatitis C virus H2B22010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
AID585727Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585703Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID243248Ratio of maximum concentration bound and specificity sum for triplex nucleic acids2004Journal of medicinal chemistry, Nov-04, Volume: 47, Issue:23
Structural selectivity of aromatic diamidines.
AID1191411Inhibition of telomerase in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA2015European journal of medicinal chemistry, Jan-27, Volume: 90Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
AID519833Antimicrobial activity against Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID516696Inhibition of telomerase in human SGC7901 cells by TRAP assay2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
AID1363348Binding affinity to Escherichia coli supercoiled pBR322 DNA assessed as TOP1-mediated unwinding effect at 0.3 to 1.2 ug/ml preincubated for 10 mins followed by TOP1 addition and measured after 30 mins by agarose gel electrophoresis2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
AID405368Toxicity against human H9c2 cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 6 days relative to control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID31893Thermal denaturation in sonicated poly(dA)-poly(dT) homopolymer (AT)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID406657Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID585685Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585493Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID339751Binding affinity to synthetic poly(dA-dT):poly(dA-dT) DNA: DNA duplex assessed as melting temperature at 2.2 uM2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Molecular recognition of a DNA:RNA hybrid: sub-nanomolar binding by a neomycin-methidium conjugate.
AID572156Activity of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation in presence of 100 mM NaCl by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID405456Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID366770Inhibition of calf thymus topoisomerase 1-mediated supercoiled plasmid pCI DNA relaxation activity at 10 uM after 30 mins by gel electrophoresis2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Novel amidino-substituted thienyl- and furylvinylbenzimidazole: derivatives and their photochemical conversion into corresponding diazacyclopenta[c]fluorenes. synthesis, interactions with DNA and RNA, and antitumor evaluation. 4.
AID585715Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585494Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585916Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586108Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406652Antibacterial activity against Staphylococcus aureus ACH-0126 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID586112Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586111Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585893Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID285528Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID1326610Inhibition of calf thymus DNA topoisomerase 1 assessed as DNA-insertion by measuring reduction in conversion of negatively supercoiled pBR322 plasmid DNA to relaxed DNA at 25 uM preincubated followed by substrate addition measured after 30 mins by ethidiu2016European journal of medicinal chemistry, Oct-21, Volume: 122Novel securinine derivatives as topoisomerase I based antitumor agents.
AID520084Antimicrobial activity against Escherichia coli TG1 harboring plasmid pEX19Gm by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID576019Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID585696Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585884Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1060709Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
AID1855985Binding affinity to DNA (unknown origin) assessed as DNA intercalation at 1 ug/ml by measuring amount of methyl green dye replaced from DNA-methyl green complex
AID586116Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID405460Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID498874Antimicrobial activity against Neisseria meningitidis M7tolC::Kan by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID1632796Binding affinity to calf thymus duplex DNA assessed as induction of ellipticity at 2.5 to 63 uM in pH 7 phosphate buffer by circular dichroism method2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
DNA-binding studies of the natural β-carboline eudistomin U.
AID1502711Antimycobacterial activity against Mycobacterium avium isolate MAV2 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID405454Antibacterial activity against Escherichia coli C600Rif by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID361640Inhibition of calf thymus topoisomerase 1 assessed as induction of supercoiled plasmid pCI DNA nicking at 10 uM after 30 mins by gel electrophoresis2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Novel amidino-substituted thienyl- and furylvinylbenzimidazole: derivatives and their photochemical conversion into corresponding diazacyclopenta[c]fluorenes. synthesis, interactions with DNA and RNA, and antitumor evaluation. 4.
AID405374Toxicity against human HepG2/C3A cells assessed as elevation of lactate levels at 0.5 ug/ml after 6 days by NAD+ reduction assay2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID585695Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406653Antibacterial activity against Staphylococcus aureus ACH-0210 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID585881Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585725Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586107Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID396284Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID1586737Inhibition of calf thymus topoisomerase-1-mediated supercoiled pBR322 DNA unwinding at 25 uM preincubated with DNA for 10 mins followed by enzyme addition and measured after 30 mins by agarose gel electrophoresis assay2018Journal of natural products, 12-28, Volume: 81, Issue:12
Eucalypglobulusals A-J, Formyl-Phloroglucinol-Terpene Meroterpenoids from Eucalyptus globulus Fruits.
AID1493962Binding affinity to calf thymus double stranded DNA at 5 uM by ostwald viscometer2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
AID523171Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC11521 harboring gyrA S84L/S85P, parC E84G mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserp2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID1326457Binding affinity to calf thymus DNA assessed as DNA intercalation by measuring conformational changes at 100 uM after 2 hrs by CD spectroscopic analysis2016European journal of medicinal chemistry, Oct-21, Volume: 122Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα.
AID586122Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID762417Antimicrobial activity against Mycobacterium smegmatis MC2 155 ATCC 700084 after 72 hrs by MTT assay2013European journal of medicinal chemistry, Aug, Volume: 667-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
AID585484Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID285529Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID585485Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID54984Thermal denaturation in sonicated calf thymus DNA (CT DNA)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1549672Binding affinity to Escherichia coli supercoiled pBR322 DNA assessed as DNA intercalation at 5 uM after 3 hrs by ethidium bromide staining-based agarose gel electrophoresis analysis2019European journal of medicinal chemistry, May-01, Volume: 169Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
AID582819Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1273398Anti-tubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294T after 7 days by mircodilution method2016European journal of medicinal chemistry, Jan-01, Volume: 107Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis.
AID489406Inhibition of human telomerase in human SGC7901 cells by TRAP assay2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents.
AID586095Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID584115Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID532580Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID585688Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585716Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406647Antibacterial activity against Staphylococcus aureus ACH-0204 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID585921Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1356633Antimicrobial activity against NorA overexpressing Staphylococcus aureus SA-K2378 by microdilution method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID406808Antibacterial activity against Staphylococcus aureus ATCC 33591 isolate after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID532759Antimicrobial activity against Salmonella serovar Montevideo 5747 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID582822Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID576017Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID585684Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585723Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID520085Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring plasmid pEX19Gm by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID405369Toxicity in human HepG2/C3A cells assessed as cell viability at 0.5 ug/ml after 10 days2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID1594141Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID759750Binding affinity to DNA (unknown origin) assessed as induction of conformational changes at 300 uM after 2 hrs by CD spectrometric analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Mahanine, a DNA minor groove binding agent exerts cellular cytotoxicity with involvement of C-7-OH and -NH functional groups.
AID285530Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID743749Binding affinity to DNA (unknown origin) at 5 mg/mL by RP-TLC plate analysis2013European journal of medicinal chemistry, May, Volume: 63Synthesis, in vitro antitumor evaluation and DNA-binding study of novel tetrahydroquinolines and some derived tricyclic and tetracyclic ring systems.
AID339764Binding affinity to synthetic poly(dA):poly(rU) DNA:RNA hybrid assessed as association constant at 20 degC2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Molecular recognition of a DNA:RNA hybrid: sub-nanomolar binding by a neomycin-methidium conjugate.
AID532757Antimicrobial activity against Salmonella serovar Kedougou by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID725721Inhibition of telomerase-mediated supercoiling activity in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors.
AID572147Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID406656Antibacterial activity against Staphylococcus aureus ACH-0203 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID582813Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID702826Induction of DNA intercalation in Escherichia coli pBR322 DNA assessed as induction of supercoiled DNA at 1 ug/ml incubated for 15 mins by electrophoresis based Top1 unwinding assay2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.
AID585724Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID576016Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID681211TP_TRANSPORTER: growth inhibition in BCRP-expressing Lactococcus lactis cells2003The Journal of biological chemistry, Jun-06, Volume: 278, Issue:23
Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis.
AID1594137Inhibition of ATPase activity of Escherichia coli GroEL expressed in Escherichia coliDH5alpha incubated for 60 mins using ATP by spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID572158Binding affinity to Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID586115Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585904Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID339765Binding affinity to synthetic poly(rA):poly(rU) DNA:RNA hybrid assessed as association constant at 20 degC2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Molecular recognition of a DNA:RNA hybrid: sub-nanomolar binding by a neomycin-methidium conjugate.
AID532758Antimicrobial activity against Salmonella serovar Mbandaka 7892 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID585905Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406810Antibacterial activity against Staphylococcus aureus ATCC 700699 isolate with gyrA Ser84Leu, Glu409Lys and grlA Ser80Phe mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID576021Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID585705Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID283559Antibacterial activity against Escherichia coli AG102MB after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID585701Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID374690Antimicrobial activity against Staphylococcus aureus K3092 overexpressing NorA gene2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID1502709Antimycobacterial activity against Mycobacterium avium ATCC 25291 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1859834Displacement of methyl green from salmon sperm DNA at 10 uM measured after 2 hrs by fluorescence plate reader method relative to control2022European journal of medicinal chemistry, Aug-05, Volume: 238Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation.
AID585915Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585495Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID368421Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID585481Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586120Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID639399Binding affinity to calf thymus DNA assessed as intercalation measuring viscosity index at compound to DNA molar ratio of 0.2 at pH 7 by viscometry method2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Novel biologically active nitro and amino substituted benzimidazo[1,2-a]quinolines.
AID285533Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA678 after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID1060710Inhibition of telomerase in human SW1116 cells after 24 hrs by TRAP-PCR-ELISA assay2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
AID586126Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID248000Concentration required to inhibit 50% of human carcinoma A2780 cell lines2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding.
AID532583Antimicrobial activity against Salmonella serovar Binza 8269 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID534106Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID582812Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID212907Inhibitory activity against telomerase (Compound released from DNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3)2001Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex.
AID576022Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID582821Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585887Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID212908Inhibitory activity against telomerase (Compound released from RNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3)2001Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex.
AID523165Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC8525 harboring wild type quinolone resistance-determining region assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 u2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID405371Toxicity in human sH9c2 cells assessed as cell viability at 0.5 ug/ml after 10 to 14 days2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID1356627Cytotoxicity in human THP1 cells assessed as reduction in cell viability incubated for 24 hrs by ATP bioluminescence assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID519834Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID585486Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585918Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585914Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585702Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID510747Antibacterial activity against Escherichia coli AG102MB harboring pSport1-based acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID771014Induction of DNA intercalation activity of calf thymus DNA topoisomerase 1 assessed as unwinding of pBR322 DNA at 2 ug/ml after 30 mins by Agarose gel electrophoresis2013European journal of medicinal chemistry, Oct, Volume: 68A novel p-terphenyl derivative inducing cell-cycle arrest and apoptosis in MDA-MB-435 cells through topoisomerase inhibition.
AID585920Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586087Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID498878Antimicrobial activity against Escherichia coli RAM1129 by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID585713Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1632788Binding affinity to calf thymus duplex DNA assessed as change in melting temperature at 2.5 uM in pH 7 phosphate buffer by UV-vis spectrophotometric analysis2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
DNA-binding studies of the natural β-carboline eudistomin U.
AID520083Antimicrobial activity against aheB-deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring AheABC efflux pump by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID523166Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC11696 assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID498877Antimicrobial activity against Escherichia coli RAM4100 by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID520081Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID586123Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585900Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585496Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID534109Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm05272008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID498876Antimicrobial activity against Neisseria meningitidis M7tolC::Kan mtr::Spc by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID572149Activity of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID1702011Binding affinity to calf thymus DNA assessed as binding constant at 298 K by double beam UV-vis spectroscopic analysis2018Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3
Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.
AID1810251Inhibition of human topoisomerase 1 assessed as DNA intercalation at 1.2 uM using relaxed pHOT-1 DNA as substrate preincubated with DNA for 10 mins followed by enzyme addition and measured after 30 mins by agarose gel electrophoresis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
AID368424Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID586119Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID523170Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC17042 harboring gyrA S84L/G106D, parC S80F and parE D732N mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID532581Antimicrobial activity against Salmonella serovar Typhimurium LT2 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID212909Inhibitory activity against telomerase (Compound released from underivatized resin2001Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex.
AID405462Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID572148Activity of Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID396281Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID405465Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID31892Thermal denaturation in alternating poly(dA-dT)poly(dA-dT) homopolymer (AT)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID1146806Induction of Escherichia coli omega enzyme-mediated relaxation of Escherichia coli (RR1) pBR313 closed circular DNA at 40 X 10'-12 mol preincubated for 10 mins followed by enzyme-addition measured after 30 mins by agarose gel electrophoretic analysis1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
2-Deaminoactinomycin D, synthesis and interaction with deoxyribonucleic acid.
AID585490Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID54425DNA binding property estimated by measuring denaturation temperature on GC to poly (dGC)-poly(dGC), normalized to ethidium bromide1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID576014Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID585714Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585491Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID532765Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of IPTG2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1651229Binding affinity at Escherichia coli pBR322 DNA assessed as unwinding of supercoiled DNA incubated for 30 mins in presence of topoisomerase 1 by agarose gel based electrophoresis2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.
AID1450867Induction of DNA damage in Escherichia coli pBR322 DNA assessed as effect on mobility rate at 5 uM after 1 hr by DNA relaxation assay2017Journal of medicinal chemistry, 08-24, Volume: 60, Issue:16
Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells.
AID1287127Inhibition of telomerase in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA method2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
AID586098Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1506607Induction of DNA intercalation assessed as reduction in topoisomerase 1-mediated DNA relaxation at 100 uM using supercoiled pBR322 DNA incubated for 0.5 hrs in presence of calf thymus topoisomerase 1 by electrophoresis method2017MedChemComm, Feb-01, Volume: 8, Issue:2
Novel bivalent securinine mimetics as topoisomerase I inhibitors.
AID54427DNA binding activity as denaturation temperatures on AT to poly (dA)-poly(dT) normalized to ethidium bromide1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID585886Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1502710Antimycobacterial activity against Mycobacterium avium isolate MAV1 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID532756Antimicrobial activity against Salmonella serovar Haifa 9878 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID774947Induction of Escherichia coli pBR322 DNA intercalating activity assessed as retardation of DNA at 1 to 2.5 uM after 20 mins by agarose gel electrophoresis2013European journal of medicinal chemistry, Nov, Volume: 693-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
AID406651Antibacterial activity against Staphylococcus aureus ACH-0218 isolate with grlA Glu84Lys mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID585898Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585882Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID285532Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA643 after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID45400Effect on cross resistance of CHO cells resistant to colchicine (CHRC5)1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Structure-activity relationships of antineoplastic agents in multidrug resistance.
AID585910Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID405459Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID405381Toxicity against human H9c2 cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 12 days relative to control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID1339143Binding affinity to synthetic biotin-labeled 30-mer GC-rich duplex DNA in pH 7.8 Tris-Hcl buffer solution assessed as association rate constant in presence of 0.1 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID1356631Antimicrobial activity against Staphylococcus aureus SA-1199B expressing wild type norA by microdilution method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID523167Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC12501 assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID405458Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID532764Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID54452Activity against DNA binding in calf thymus was determined1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Amplification of bleomycin-mediated degradation of DNA.
AID54646Intrinsic association constant for DNA2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Synthesis of a novel intercalator based on 2,2'-binaphthalene bearing dimethylammonium groups.
AID395135Binding affinity to poly(A).poly(U) RNA assessed as change in melting temperature2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?
AID585686Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID582814Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID233938Ratio between poly-dAdT and poly-dGdC binding1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID1339144Binding affinity to synthetic biotin-labeled 30-mer GC-rich duplex DNA in pH 7.8 Tris-Hcl buffer solution assessed as dissociation rate constant in presence of 0.1 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID585483Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID735444Inhibition of telomerase in human SGC7901 cells by TRAP assay2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
AID374687Antimicrobial activity against Staphylococcus aureus NCTC 8325-4 expressing NorA gene2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID406809Antibacterial activity against Staphylococcus aureus NY2746 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID406806Antibacterial activity against Staphylococcus aureus ACH-0201 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID585885Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID538150Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to absorbance of compound at 100 uM after 24 hrs by UV spectrophotometer analysis2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Structural modifications on the phenazine N,N'-dioxide-scaffold looking for new selective hypoxic cytotoxins.
AID584114Antibacterial activity against Escherichia coli KAM32 harboring Staphylococcus aureus cloned pSP72 lmrS by broth microdilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID532582Antimicrobial activity against Salmonella serovar Typhimurium 14028S by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID585692Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1855986Binding affinity to DNA (unknown origin) assessed as DNA intercalation at 10 ug/ml by measuring amount of methyl green dye replaced from DNA-methyl green complex
AID396280Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID406811Antibacterial activity against Staphylococcus aureus BSA643 isolate with gyrA Ser84Leu and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID586128Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1339147Binding affinity to synthetic biotin-labeled 30-mer GC-rich duplex DNA in pH 7.8 Tris-Hcl buffer solution assessed as ratio of association rate constant to dissociation rate constant in presence of 0.1 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID585487Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID339753Binding affinity to synthetic poly(rA):poly(rU) RNA:RNA duplex assessed as melting temperature at 2.2 uM2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Molecular recognition of a DNA:RNA hybrid: sub-nanomolar binding by a neomycin-methidium conjugate.
AID534107Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID534112Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm19802008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID532754Antimicrobial activity against Salmonella serovar Hadar by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID585730Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID368915Antimicrobial activity against methicillin-resistant Staphylococcus aureus effluxing isolate2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.
AID576018Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID510750Antibacterial activity against Escherichia coli AG102MB harboring pS1328-based acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID585890Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID396042Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID406654Antibacterial activity against Staphylococcus aureus ACH-0186 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID1502706Antimycobacterial activity against Mycobacterium avium 104 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID586127Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID283558Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID615635Displacement of methyl green dye from DNA after 24 hrs by spectrophotometric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines.
AID585897Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID339754Binding affinity to synthetic poly(dA):poly(rU) DNA:RNA hybrid assessed as melting temperature at 2.2 uM2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Molecular recognition of a DNA:RNA hybrid: sub-nanomolar binding by a neomycin-methidium conjugate.
AID405377Toxicity against human H9c2 cells assessed as increase in mitochondrial superoxide production at 0.5 ug/ml after 4 to 14 days by flow cytometry2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID586092Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585720Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID582823Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585891Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID498875Antimicrobial activity against Neisseria meningitidis M7mtrE::Spc by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID53470Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors.
AID586109Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID405367Toxicity against human sHepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 6 days relative to control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID487000Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to the absorbance at 100 uM after 24 hrs by UV spectrophotometer analysis relative to control2010Bioorganic & medicinal chemistry, Jun-15, Volume: 18, Issue:12
Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID405468Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID368419Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID585895Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID23271Partition coefficient (logD7.4)1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Structure-activity relationships of antineoplastic agents in multidrug resistance.
AID586124Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585682Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID537601Inhibition of telomerase in human SGC7901 cells by TRAP assay2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
AID585693Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586110Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID695925Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Inhibition of therapeutically important polymerases with high affinity bis-intercalators.
AID520088Antimicrobial activity against Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
AID405457Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID54423Denaturation temperature change on binding to AT to poly (dA)-poly(dT)1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID1356635Antimicrobial activity against mepA overexpressing Staphylococcus aureus SA-K2886 by microdilution method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID585880Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586093Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID357846Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method
AID584118Inhibition of Staphylococcus aureus LmrS expressed in Escherichia coli KAM32 harboring pSP72 assessed as decrease of ethidium bromide accumulation at 100 uM by fluorescence spectrophotometer relative to control2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID248001Concentration required to inhibit 50% of human carcinoma SKOV3 cell lines2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding.
AID405378Toxicity against human HepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 4 days relative to control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID585687Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585704Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID532760Antimicrobial activity against Salmonella serovar Newport 129 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID572157Binding affinity to Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID472812Cytotoxicity against human HBI10A cells2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
AID585733Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID405469Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID585718Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID285531Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID585699Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585917Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1356626Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 24 hrs by ATP bioluminescence assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
AID523168Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC8530 harboring gyrA S84L and parC I143V mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpin2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID532766Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of chlorpromzine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID576023Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
AID585906Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID374688Antimicrobial activity against NorA deficient Staphylococcus aureus K17582007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
AID585894Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID498880Antimicrobial activity against Escherichia cloi RAM1129 transfected with pNK1 containg Neisseria meningitidis tolC gene by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID639393Binding affinity to calf thymus DNA assessed as binding constant at pH 7 by fluorescence quenching assay2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Novel biologically active nitro and amino substituted benzimidazo[1,2-a]quinolines.
AID585489Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1594134Inhibition of native soluble pig heart MDH assessed as reduction in MDH enzyme activity using sodium mesoxalate as substrate and NADH by malachite green dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID405380Toxicity against human HepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 14 days relative to control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID368918Inhibition of multidrug-resistant efflux pump in methicillin-resistant Staphylococcus aureus effluxing isolate assessed as fold reduction of ethidium-bromide MIC at 10 ug/ml by microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.
AID405463Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID357845Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method
AID534108Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID586091Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1352098Induction of Escherichia coli pBR322 DNA intercalation assessed as transformation of topoisomerase1-relaxed pBR322 DNA in to supercoiled DNA preincubated for 10 mins followed by topoisomerase-1 addition measured after 30 mins by agarose gel electrophoresi2018European journal of medicinal chemistry, Feb-10, Volume: 145Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.
AID585709Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID396283Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID585488Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID582820Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID582816Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585717Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID472814Selectivity index, ratio of CC50 for human HBI10A cells to EC50 for Hepatitis C virus2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
AID585721Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585690Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID405376Toxicity against human HepG2/C3A cells assessed as increase in mitochondrial superoxide production at 0.5 ug/ml after 4 to 14 days by flow cytometry2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID586094Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID368420Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID585889Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID54424Denaturation temperature change on binding on GC to poly(dGC)-poly(dGC)1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID585923Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID534111Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID405372Toxicity against human HepG2/C3A cells assessed as inhibition of cell proliferation at 0.5 ug/ml after 6 days by SRB assay2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID585896Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585922Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1502712Antimycobacterial activity against Mycobacterium avium isolate MAV3 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID368418Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1891166Inhibition of topoisomerase 1 (unknown origin) assessed as DNA intercalation at 1 mM using pBR322 DNA as substrate measured after 30 mins by gel electrophoresis relative to control2022Bioorganic & medicinal chemistry, 05-01, Volume: 61Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.
AID406650Antibacterial activity against Staphylococcus aureus ACH-0216 isolate with grlA Ser80Phe mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID498879Antimicrobial activity against Escherichia cloi RAM1129 transfected with pGCC4 containg IPTG-inducible lacZ promoter by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID1374954Inhibition of human topoisomerase-2 assessed as DNA intercalation by measuring relaxation of supercoiled pBR322 plasmid DNA at 0.3 to 2.5 uM after 6 mins by agarose gel electrophoresis2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.
AID1204358Inhibition of telomerase in human MDA-MB-231 cells after 24 hrs by TRAP-PCR-ELISA2015European journal of medicinal chemistry, Jun-05, Volume: 97Novel myricetin derivatives: Design, synthesis and anticancer activity.
AID405466Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID586100Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID572151Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID586105Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585883Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1379617Binding affinity to calf thymus DNA assessed as increase in relative viscosity of DNA-compound complex at 5 uM by viscometry2017European journal of medicinal chemistry, Nov-10, Volume: 140Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies.
AID585732Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID54426Denaturation temperature change on binding to calf thymus DNA1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID586117Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID594636Inhibition of telomerase activity expressed in human SGC7901 cells by SYBER green dye based TRAP2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
AID405464Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID586125Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID582817Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID523169Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC4222 harboring gyrA S84L and parC S80F mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
AID512633Binding affinity to human c-MYC Pu24I G-quadruplex structure assessed as stabilization of G-quadruplex by NMR spectroscopy2005Nature chemical biology, Aug, Volume: 1, Issue:3
Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter.
AID585722Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585694Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID406807Antibacterial activity against Staphylococcus aureus ACH-0141 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID405461Antibacterial activity against Escherichia coli TOP10 by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID1632804Binding affinity to calf thymus duplex DNA assessed as melting temperature at 0.5 mM by differential scanning calorimetry (Rvb = 51 degC)2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
DNA-binding studies of the natural β-carboline eudistomin U.
AID660264Ratio of MIC for wild type Escherichia coli HS414 to MIC for acrB-deficient Escherichia coli HS832 by agar dilution method2012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID586121Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID534110Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID586101Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID586089Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID585700Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID498873Antimicrobial activity against Neisseria meningitidis M7 by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
AID585909Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID247965Concentration required to inhibit 50% of human carcinoma CH1 cell lines2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding.
AID585719Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID1537210Binding affinity to calf thymus DNA assessed as DNA intercalation by measuring increase in viscosity at 5 uM by Ostwald viscometric method2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
Synthesis and biological evaluation of pyrazole linked benzothiazole-β-naphthol derivatives as topoisomerase I inhibitors with DNA binding ability.
AID368423Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID585903Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID753092Binding affinity to calf thymus DNA after 1.5 hrs by spectroscopic titration2013European journal of medicinal chemistry, Jun, Volume: 64Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group.
AID572150Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID368422Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID586090Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID653484Inhibition of telomerase supercoiling activity in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA assay2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.
AID406813Antibacterial activity against Staphylococcus aureus ACH-0231 isolate with gyrA Ser84Leu, Glu88Lys and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
AID405370Toxicity in human HepG2/C3A cells assessed as cell viability at 0.5 ug/ml after 14 days2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.
AID585726Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
AID743748Displacement of methyl green from DNA (unknown origin) after 24 hrs2013European journal of medicinal chemistry, May, Volume: 63Synthesis, in vitro antitumor evaluation and DNA-binding study of novel tetrahydroquinolines and some derived tricyclic and tetracyclic ring systems.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID720501qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds2012PloS one, , Volume: 7, Issue:10
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (115)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (3.48)18.7374
1990's3 (2.61)18.2507
2000's24 (20.87)29.6817
2010's71 (61.74)24.3611
2020's13 (11.30)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 87.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index87.72 (24.57)
Research Supply Index4.76 (2.92)
Research Growth Index5.65 (4.65)
Search Engine Demand Index152.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (87.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.72%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other114 (98.28%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]